Cyclopharm Limited (ASX:CYC)
0.5000
0.00 (0.00%)
Jun 26, 2026, 3:25 PM AEST
Cyclopharm Market Cap
Cyclopharm has a market cap or net worth of 63.03 million as of June 26, 2026. Its market cap has decreased by -44.94% in one year.
Market Cap
63.03M
Enterprise Value
64.15M
Revenue
32.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since January 18, 2007, Cyclopharm's market cap has increased from 50.89M to 63.03M, an increase of 23.86%. That is a compound annual growth rate of 1.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 63.03M | -42.13% |
| Dec 30, 2025 | 108.91M | -38.17% |
| Dec 31, 2024 | 176.15M | -2.75% |
| Dec 29, 2023 | 181.14M | 66.37% |
| Dec 30, 2022 | 108.87M | -28.90% |
| Dec 30, 2021 | 153.13M | -23.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 55.07B |
| Sigma Healthcare | 31.40B |
| Pro Medicus | 18.70B |
| Sonic Healthcare | 9.81B |
| INOVIQ | 73.20M |
| Mach7 Technologies | 71.68M |
| Cleo Diagnostics | 67.75M |
| Radiopharm Theranostics | 67.34M |